WALDENSTROM'S DISEASE
Clinical trials for WALDENSTROM'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM'S DISEASE trials appear
Sign up with your email to follow new studies for WALDENSTROM'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may predict relapse in rare blood cancer
Knowledge-focused Recruiting nowThis study explores whether detecting tumor DNA in the blood after 6 months of treatment can help predict if Waldenström Macroglobulinemia will return within 3 years. Researchers will follow 90 patients who need treatment for this slow-growing blood cancer. The goal is to improve…
Matched conditions: WALDENSTROM'S DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC
-
Researchers seek better ways to predict Waldenstrom's outcomes
Knowledge-focused Recruiting nowThis study aims to improve how doctors predict the course of Waldenstrom's macroglobulinemia, a rare blood cancer. Researchers will analyze data from 500 patients to validate existing prognostic indexes and evaluate whether progression-free survival can reliably predict overall s…
Matched conditions: WALDENSTROM'S DISEASE
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC